Search research articles
Contact Us
Filters
Showing results (311-320 of 319) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 319 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
L Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries
L Kandolf Sekulovic, J Guo, S Agarwala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
L Kandolf Sekulovic, K Peris, A Hauschild, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force
C Garbe, K Peris, E Soura, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 4, 2024
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
C Gaudy-Marqueste, J J Grob, C Garbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
P Grover, S N Lo, I Li, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 319) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 319 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
L Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries
L Kandolf Sekulovic, J Guo, S Agarwala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
L Kandolf Sekulovic, K Peris, A Hauschild, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force
C Garbe, K Peris, E Soura, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 4, 2024
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
C Gaudy-Marqueste, J J Grob, C Garbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
P Grover, S N Lo, I Li, et al.
Page
of 32